TIAA Trust, National Association
AZN icon

TIAA Trust, National Association’s AstraZeneca AZN Stock Holding History

TIAA Trust, National Association’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-102
Closed -$20.1K – 348
2026
Q1 		$20.1K Sell
102
-5,510
-98% -$1.06M ﹤0.01% 350
2025
Q4 		$1.03M Sell
5,612
-527
-9% -$92.4K ﹤0.01% 377
2025
Q3 		$942K Buy
6,139
+290
+5% +$43.9K ﹤0.01% 397
2025
Q2 		$817K Sell
5,849
-624
-10% -$87.5K ﹤0.01% 409
2025
Q1 		$952K Buy
6,473
+110
+2% +$15.9K ﹤0.01% 373
2024
Q4 		$834K Sell
6,363
-24,364
-79% -$3.41M ﹤0.01% 387
2024
Q3 		$4.79M Sell
30,727
-62,608
-67% -$10.1M 0.01% 228
2024
Q2 		$14.6M Sell
93,335
-24,465
-21% -$3.68M 0.04% 147
2024
Q1 		$16M Buy
117,800
+8,449
+8% +$1.12M 0.05% 144
2023
Q4 		$14.7M Sell
109,351
-14,810
-12% -$1.93M 0.05% 144
2023
Q3 		$16.8M Buy
+124,161
New +$17M 0.06% 128

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

TIAA Trust, National Association's AZN Position: Q2 2026 in Review

TIAA Trust, National Association sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 102 shares — an estimated $20.1K sold.

TIAA Trust, National Association first reported a position in AZN in Q3 2023 and held it in 11 quarters. The position peaked at $16.8M in Q3 2023. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • TIAA Trust, National Association reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • TIAA Trust, National Association sold 102 AstraZeneca shares in Q2 2026, an estimated $20.1K.
  • TIAA Trust, National Association first reported a position in AstraZeneca in Q3 2023 and held it in 11 quarters.
  • TIAA Trust, National Association's AstraZeneca position peaked at $16.8M in Q3 2023.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on TIAA Trust, National Association's 13F filing for Q2 2026, filed 10 Aug 2026.